A novel mechanism of nuclear factor κB activation through the binding between inhibitor of nuclear factor-κBα and the processed NH2-terminal region of Mig-6

Cancer Research

Volumn 62, Issue 20, 2002, Pages 5668-5671

  Tsunoda, Toshiyuki ^a,b   Inokuchi, Junichi ^a,b   Baba, Iwai ^a   Okumura, Koji ^b   Naito, Seiji ^b   Shirasawa, Senji ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EARLY RESPONSE GENE; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; MITOGENE INDUCIBLE GENE 6; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING; TRANSCRIPTION INITIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; CARRIER PROTEINS; DNA-BINDING PROTEINS; HUMANS; I-KAPPA B PROTEINS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PRECIPITIN TESTS; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037108872     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Burbelo, P. D., Drechsel, D., and Hall, A. A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases. J. Biol. Chem., 270: 29071-29074, 1995
2. Pirone, D. M., Carter, D. E., and Burbelo, P. D. Evolutionary expansion of CRIB-containing Cdc42 effector proteins. Trends Genet., 17: 370-373, 2001
3. Makkinje, A., Quinn, D. A., Chen, A., Cadilla, C. L., Force, T., Bonventre, J. V., and Kyriakis, J. M. Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. J. Biol. Chem., 275: 17838-17847, 2000
4. Lee, K-L., Isham, K. R., Stringfellow, L., Rothrock, R., and Kenney, F. T. Molecular cloning of cDNAs cognate to genes sensitive to hormonal control in rat liver. J. Biol. Chem., 260: 16433-16438, 1985
5. Weinstock, R. S., and Messina, J. L. Vanadate and insulin stimulate gene 33 expression. Biochem. Biophys. Res. Commun., 189: 931-937, 1992
6. Wolf, G., and Ziyadeh, F. N. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int., 56: 393-405, 1999
7. Mahgoub, M. A., and Abd-Elfattah, A. S. Diabetes mellitus and cardiac function. Mol. Cell. Biochem., 180: 59-64, 1998
8. Baldwin, A. S. The NF-κB and IκB proteins: New discoveries and insights. Annu Anna. Rev. Immunol., 14: 649-683, 1996
9. Barnes, P. J., and Karin, M. Nuclear factor-κ B: A pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med., 336: 1066-1071, 1997
10. Makarov, S. S. NF-κB as a therapeutic target in chronic inflammation: Recent advances. Mol. Med. Today, 6: 441-448, 2000
11. Karin, M., Cao, Y., Greten, F. R., and Li, Z. W. NF-κB in cancer: From innocent bystander to major culprit. Nat. Rev. Cancer, 2: 301-310, 2002
12. Okumura, K., Shirasawa, S., Nishioka, M., and Sasazuki, T. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells. Cancer Res., 59: 2445-2450, 1999
13. Cammarano, M. S., and Minden, A. Dbl and the Rho GTPases activate NFκB by IKK-dependent and IKK-independent pathways. J. Biol. Chem., 276: 25876-25882, 2001
14. Shirasawa, S., Furuse, M., Yokoyama, N., and Sasazuki, T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science (Wash. DC), 260: 85-88, 1993
15. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science (Wash. DC), 267: 1485-1491, 1995
16. Mott, H. R., Owen, D., Nietlispach, D., Lowe, P. N., Manser, E., Lim, L., and Laue, E. D. Structure of the small G protein Cdc42 bound to the GTPase-binding domain of ACK. Nature (Lond.), 399: 384-388, 1999
17. Huxford, T., Huang, D. B., Malek, S., and Ghosh, G. The crystal structure of the IκBα/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell, 95: 759-770, 1998
18. 1 progression and differentiation. Exp. Cell Res., 219: 527-535, 1995
19. Rayet, B., and Gelinas, C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene, 18: 6938-6947, 1999
20. Baba, I., Shirasawa, S., Iwamoto, R., Okumura, K., Tsunoda, T., Nishioka, M., Fukuyama, K., Yamamoto, K., Mekada, E., and Sasazuki, T. Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells. Cancer Res., 60: 6886-6889, 2000